Literature DB >> 32641473

Novel Proteome Extraction Method Illustrates a Conserved Immunological Signature of MSI-H Colorectal Tumors.

Elez D Vainer1, Juliane Kania-Almog2, Ghadeer Zatara3, Yishai Levin4, Gilad W Vainer5.   

Abstract

Using a simple, environment friendly proteome extraction (TOP), we were able to optimize the analysis of clinical samples. Using our TOP method we analyzed a clinical cohort of microsatellite stable (MSS) and unstable (MSI-H) colorectal carcinoma (CRC). We identified a tumor cell specific, STAT1-centered, immune signature expressed by the MSI-H tumor cells. We then showed that long, but not short, exposure to Interferon-γ induces a similar signature in vitro We identified 10 different temporal protein expression patterns, classifying the Interferon-γ protein temporal regulation in CRC. Our data sheds light on the changes that tumor cells undergo under long-term immunological pressure in vivo, the importance of STAT proteins in specific biological scenarios. The data generated could help find novel clinical biomarkers and therapeutic approaches.
© 2020 Vainer et al.

Entities:  

Keywords:  Clinical proteomics; colorectal cancer; immunohistochemistry; immunology; inflammatory response; label-free quantification; molecular biology

Year:  2020        PMID: 32641473      PMCID: PMC8015011          DOI: 10.1074/mcp.RA120.002152

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  61 in total

1.  T cell responses against microsatellite instability-induced frameshift peptides and influence of regulatory T cells in colorectal cancer.

Authors:  Kathrin Bauer; Nina Nelius; Miriam Reuschenbach; Moritz Koch; Jürgen Weitz; Gunnar Steinert; Jürgen Kopitz; Philipp Beckhove; Mirjam Tariverdian; Magnus von Knebel Doeberitz; Matthias Kloor
Journal:  Cancer Immunol Immunother       Date:  2012-06-23       Impact factor: 6.968

Review 2.  The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses.

Authors:  Katarzyna Blaszczyk; Hanna Nowicka; Kaja Kostyrko; Aleksandra Antonczyk; Joanna Wesoly; Hans A R Bluyssen
Journal:  Cytokine Growth Factor Rev       Date:  2016-03-18       Impact factor: 7.638

Review 3.  Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine.

Authors:  Laetitia Nebot-Bral; David Brandao; Loic Verlingue; Etienne Rouleau; Olivier Caron; Emmanuelle Despras; Yolla El-Dakdouki; Stéphane Champiat; Said Aoufouchi; Alexandra Leary; Aurélien Marabelle; David Malka; Nathalie Chaput; Patricia L Kannouche
Journal:  Eur J Cancer       Date:  2017-08-29       Impact factor: 9.162

4.  Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1.

Authors:  A Muhlethaler-Mottet; W Di Berardino; L A Otten; B Mach
Journal:  Immunity       Date:  1998-02       Impact factor: 31.745

5.  Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma.

Authors:  Fee Klupp; Johannes Diers; Christoph Kahlert; Lena Neumann; Niels Halama; Clemens Franz; Thomas Schmidt; Felix Lasitschka; Arne Warth; Juergen Weitz; Moritz Koch; Martin Schneider; Alexis Ulrich
Journal:  Ann Surg Oncol       Date:  2015-03-13       Impact factor: 5.344

6.  Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta.

Authors:  J F Piskurich; M W Linhoff; Y Wang; J P Ting
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

7.  Frequent mutations in the 3'-untranslated region of IFNGR1 lack functional impairment in microsatellite-unstable colorectal tumours.

Authors:  Jan Willem F Dierssen; Marjo van Puijenbroek; David A Dezentjé; Gert Jan Fleuren; Cees J Cornelisse; Tom van Wezel; Rienk Offringa; Hans Morreau
Journal:  Eur J Hum Genet       Date:  2008-04-16       Impact factor: 4.246

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  Proteomic sample preparation from formalin fixed and paraffin embedded tissue.

Authors:  Jacek R Wiśniewski
Journal:  J Vis Exp       Date:  2013-09-02       Impact factor: 1.355

10.  Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens.

Authors:  E Baixeras; B Huard; C Miossec; S Jitsukawa; M Martin; T Hercend; C Auffray; F Triebel; D Piatier-Tonneau
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.